TellBio, Inc.

ANDOVER, MA · Founded 2019 · CIK 0001791842 · Biotech · Private

Circulating tumor cell (CTC) detection and isolation technology platform with complementary cancer therapeutics

tellbio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$11M
5 Form D · Oct 2024
24 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$1,478,331
Private capital raisedForm D · SEC$4,999,998
Private capital raisedForm D · SEC$2,294,702
Private capital raisedForm D · SEC$1,200,000
Private capital raisedForm D · SEC$1,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1760Iterative Therapeutics Inc.——
1761Rhodium Scientific, LLC——
1762Klogene Therapeutics, Inc.——
1763TellBio, Inc.—$11M
1764Trilo Therapeutics, Inc.——
1765Phaeno Inc——
1766Akeso Biomedical, Inc.—$2.1M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 8 related persons
  • Gary CrockerDirector
  • GARY CROCKERDirector
  • Pritesh GandhiDirector · Executive Officer
  • PRITESH GANDHIDirector · Executive Officer
  • Bernard PetersDirector
  • Richard PetersDirector · Executive Officer
  • RICHARD PETERSDirector · Executive Officer
  • BERNARD PETERSDirector

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.